Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial-Reference-Cited by-同舟云学术

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

Published:2001-02 Issue:4 Volume:8 Page:308-315
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Mulvihill S,Warren R,Venook A,Adler A,Randlev B,Heise C,Kirn D

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301398.pdf

Reference27 articles.

1. Abbruzzese J, Evans D, Rich T . Cancer of the pancreas. In: V DeVita, S Hellman, S Rosenberg (eds) Cancer: Principles and Practice of Oncology 5th edn: Lippincott-Raven: Philadelphia 1997 pp 1054–1086

2. Burris H et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 1997 15: 2403–2413

3. Barton CM et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer Br J Cancer 1991 64: 1076–1082

4. Pellegata N et al. K-ras and p53 mutations in pancreatic cancer: ductal and non-ductal tumors progress through different genetic lesions Cancer Res 1994 54: 1556–1562

5. Chang F, Syrjanen S, Syrjanen K . Implications of the p53 tumor-suppressor gene in clinical oncology J Clin Oncol 1995 13: 1009–1022

Cited by 255 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade;Biomedicine & Pharmacotherapy;2023-05

2. Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials;Journal of Cancer Research and Clinical Oncology;2023-04-08

3. Review of Safety Data for Adenovirus 5 as a Delivery Vector for Intratumoral Cancer Gene Therapy;Human Gene Therapy;2023-04-01

4. Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors;Molecular Therapy - Oncolytics;2023-03

5. Current Clinical Landscape of Immunotherapeutic Approaches in Pancreatic Cancer Treatment;Interdisciplinary Cancer Research;2023